Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 402

1.
2.
3.

Trends in out-of-pocket medical care expenditures for Medicare-age adults with arthritis between 1998 and 2004.

Lurie IZ, Dunlop DD, Manheim LM.

Arthritis Rheum. 2008 Aug;58(8):2236-40. doi: 10.1002/art.23731.

4.

Out-of-pocket healthcare expenditures of older Americans with depression.

Harman JS, Kelleher KJ, Reynolds CF, Pincus HA.

J Am Geriatr Soc. 2004 May;52(5):809-13.

PMID:
15086667
5.

Outpatient prescription drug utilization and expenditure patterns of noninstitutionalized aged Medicare beneficiaries.

LaVange LM, Silverman HA.

Natl Med Care Util Expend Surv B. 1987 Apr;(12):1-43.

PMID:
10313516
6.

The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.

Park T, Jung J.

J Manag Care Spec Pharm. 2017 Jan;23(1):5-12. doi: 10.18553/jmcp.2017.23.1.5.

7.

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.

Goedken AM, Urmie JM, Farris KB, Doucette WR.

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

PMID:
20511109
8.

Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.

Conwell LJ, Esposito D, Garavaglia S, Meadows ES, Colby M, Herrera V, Goldfarb S, Ball D, Marciniak M.

Am J Geriatr Pharmacother. 2011 Aug;9(4):241-9. doi: 10.1016/j.amjopharm.2011.04.009. Epub 2011 May 26.

PMID:
21616722
9.

The impact of Medicare Part D on prescription drug use by the elderly.

Lichtenberg FR, Sun SX.

Health Aff (Millwood). 2007 Nov-Dec;26(6):1735-44.

10.

National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US.

Kim MH, Lin J, Kreilick C.

Adv Ther. 2009 Aug;26(8):784-94. doi: 10.1007/s12325-009-0054-1. Epub 2009 Aug 18.

PMID:
19690820
11.

The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.

Yin W, Basu A, Zhang JX, Rabbani A, Meltzer DO, Alexander GC.

Ann Intern Med. 2008 Feb 5;148(3):169-77. Epub 2008 Jan 7.

PMID:
18180465
12.
13.

The Medicare Part D doughnut hole: effect on pharmacy utilization.

Sun SX, Lee KY.

Manag Care Interface. 2007 Sep;20(9):51-5, 59.

PMID:
18161394
14.

Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.

Blumberg DM, Prager AJ, Liebmann JM.

JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.

PMID:
26720853
15.

Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.

Martin BI, Turner JA, Mirza SK, Lee MJ, Comstock BA, Deyo RA.

Spine (Phila Pa 1976). 2009 Sep 1;34(19):2077-84. doi: 10.1097/BRS.0b013e3181b1fad1.

PMID:
19675510
16.

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?

Mott DA, Thorpe JM, Thorpe CT, Kreling DH, Gadkari AS.

Res Social Adm Pharm. 2010 Jun;6(2):90-9. doi: 10.1016/j.sapharm.2010.02.004.

17.

Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expenditures.

Basu A, Yin W, Alexander GC.

Health Serv Res. 2010 Feb;45(1):133-51. doi: 10.1111/j.1475-6773.2009.01065.x. Epub 2009 Dec 4.

19.

Cost minimization of medicare part D prescription drug plan expenditures.

Patel RA, Lipton HL, Cutler TW, Smith AR, Tsunoda SM, Stebbins MR.

Am J Manag Care. 2009 Aug;15(8):545-53.

20.

Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer.

Davidoff AJ, Erten M, Shaffer T, Shoemaker JS, Zuckerman IH, Pandya N, Tai MH, Ke X, Stuart B.

Cancer. 2013 Mar 15;119(6):1257-65. doi: 10.1002/cncr.27848. Epub 2012 Dec 7.

Supplemental Content

Support Center